Hi Everyone! A new immunotherapy called Tecentriq showed positive results in a study of patients with lung cancer. This new treatment could be FDA approved for the treatment of lung cancer as early as October. Tecentriq works a bit differently than currently available immunotherapies so it will be exciting to have another option.